The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is initiating a novel Revolving Facility aimed at securing better supply conditions for global health products for the countries it supports.

“The Revolving Facility will help accelerate affordable access to more effective health products for people living in the poorest communities around the world,” said Peter Sands, Executive Director of the Global Fund. “As one of the largest multilateral investors in global health, the Global Fund will use the Revolving Facility to play an even more strategic role in shaping the global supply of life-saving HIV, TB and malaria products – to save lives and increase equitable access. This mechanism will also help us move even more swiftly in response to future health crises, including pandemics.”

The first agreement to come through the Facility will be with Vestergaard, manufacturers of PermaNet® malaria mosquito nets, for its new dual active ingredient (Dual AI) insecticide-treated net. Dual AI nets are more effective against insecticide-resistant mosquitoes than conventional ones. By implementing an innovative operating model, the Global Fund aims to secure sustainable prices for a set of commonly used specifications for Dual AI nets that are comparable to existing nets. This makes it possible for countries to expand coverage with Dual AI nets despite constrained budgets.

Leveraging the Revolving Facility, the innovative operating model will reduce production complexity and improve responsiveness, leading to additional cost savings across the insecticide-treated nets supply chain.

Read more